Cargando…
Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa
BACKGROUND: Retinitis pigmentosa (RP) is a hereditary retinal disease which leads to visual impairment. The onset and progression of RP has physiological consequences that affects the ocular environment. Some of the key non-genetic factors which hasten the retinal degeneration in RP include oxidativ...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575261/ https://www.ncbi.nlm.nih.gov/pubmed/36253797 http://dx.doi.org/10.1186/s13023-022-02528-x |
_version_ | 1784811280160260096 |
---|---|
author | Mohan, K. Varsha Mishra, Alaknanda Muniyasamy, Abaranjitha Sinha, Prakriti Sahu, Parul Kesarwani, Ashwani Jain, Kshama Nagarajan, Perumal Scaria, Vinod Agarwal, Manisha Akhter, Naseem S. Gupta, Chanda Upadhyay, Pramod |
author_facet | Mohan, K. Varsha Mishra, Alaknanda Muniyasamy, Abaranjitha Sinha, Prakriti Sahu, Parul Kesarwani, Ashwani Jain, Kshama Nagarajan, Perumal Scaria, Vinod Agarwal, Manisha Akhter, Naseem S. Gupta, Chanda Upadhyay, Pramod |
author_sort | Mohan, K. Varsha |
collection | PubMed |
description | BACKGROUND: Retinitis pigmentosa (RP) is a hereditary retinal disease which leads to visual impairment. The onset and progression of RP has physiological consequences that affects the ocular environment. Some of the key non-genetic factors which hasten the retinal degeneration in RP include oxidative stress, hypoxia and ocular inflammation. In this study, we investigated the status of the ocular immune privilege during retinal degeneration and the effect of ocular immune changes on the peripheral immune system in RP. We assessed the peripheral blood mononuclear cell stimulation by retinal antigens and their immune response status in RP patients. Subsequently, we examined alterations in ocular immune privilege machineries which may contribute to ocular inflammation and disease progression in rd1 mouse model. RESULTS: In RP patients, we observed a suppressed anti-inflammatory response to self-retinal antigens, thereby indicating a deviated response to self-antigens. The ocular milieu in rd1 mouse model indicated a significant decrease in immune suppressive ligands and cytokine TGF-B1, and higher pro-inflammatory ocular protein levels. Further, blood–retinal-barrier breakdown due to decrease in the expression of tight junction proteins was observed. The retinal breach potentiated pro-inflammatory peripheral immune activation against retinal antigens and caused infiltration of the peripheral immune cells into the ocular tissue. CONCLUSIONS: Our studies with RP patients and rd1 mouse model suggest that immunological consequences in RP is a contributing factor in the progression of retinal degeneration. The ocular inflammation in the RP alters the ocular immune privilege mechanisms and peripheral immune response. These aberrations in turn create an auto-reactive immune environment and accelerate retinal degeneration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02528-x. |
format | Online Article Text |
id | pubmed-9575261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95752612022-10-18 Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa Mohan, K. Varsha Mishra, Alaknanda Muniyasamy, Abaranjitha Sinha, Prakriti Sahu, Parul Kesarwani, Ashwani Jain, Kshama Nagarajan, Perumal Scaria, Vinod Agarwal, Manisha Akhter, Naseem S. Gupta, Chanda Upadhyay, Pramod Orphanet J Rare Dis Research BACKGROUND: Retinitis pigmentosa (RP) is a hereditary retinal disease which leads to visual impairment. The onset and progression of RP has physiological consequences that affects the ocular environment. Some of the key non-genetic factors which hasten the retinal degeneration in RP include oxidative stress, hypoxia and ocular inflammation. In this study, we investigated the status of the ocular immune privilege during retinal degeneration and the effect of ocular immune changes on the peripheral immune system in RP. We assessed the peripheral blood mononuclear cell stimulation by retinal antigens and their immune response status in RP patients. Subsequently, we examined alterations in ocular immune privilege machineries which may contribute to ocular inflammation and disease progression in rd1 mouse model. RESULTS: In RP patients, we observed a suppressed anti-inflammatory response to self-retinal antigens, thereby indicating a deviated response to self-antigens. The ocular milieu in rd1 mouse model indicated a significant decrease in immune suppressive ligands and cytokine TGF-B1, and higher pro-inflammatory ocular protein levels. Further, blood–retinal-barrier breakdown due to decrease in the expression of tight junction proteins was observed. The retinal breach potentiated pro-inflammatory peripheral immune activation against retinal antigens and caused infiltration of the peripheral immune cells into the ocular tissue. CONCLUSIONS: Our studies with RP patients and rd1 mouse model suggest that immunological consequences in RP is a contributing factor in the progression of retinal degeneration. The ocular inflammation in the RP alters the ocular immune privilege mechanisms and peripheral immune response. These aberrations in turn create an auto-reactive immune environment and accelerate retinal degeneration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02528-x. BioMed Central 2022-10-17 /pmc/articles/PMC9575261/ /pubmed/36253797 http://dx.doi.org/10.1186/s13023-022-02528-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Mohan, K. Varsha Mishra, Alaknanda Muniyasamy, Abaranjitha Sinha, Prakriti Sahu, Parul Kesarwani, Ashwani Jain, Kshama Nagarajan, Perumal Scaria, Vinod Agarwal, Manisha Akhter, Naseem S. Gupta, Chanda Upadhyay, Pramod Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa |
title | Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa |
title_full | Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa |
title_fullStr | Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa |
title_full_unstemmed | Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa |
title_short | Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa |
title_sort | immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575261/ https://www.ncbi.nlm.nih.gov/pubmed/36253797 http://dx.doi.org/10.1186/s13023-022-02528-x |
work_keys_str_mv | AT mohankvarsha immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT mishraalaknanda immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT muniyasamyabaranjitha immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT sinhaprakriti immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT sahuparul immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT kesarwaniashwani immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT jainkshama immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT nagarajanperumal immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT scariavinod immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT agarwalmanisha immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT akhternaseems immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT guptachanda immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa AT upadhyaypramod immunologicalconsequencesofcompromisedocularimmuneprivilegeaccelerateretinaldegenerationinretinitispigmentosa |